Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2000
07/06/2000WO2000039314A1 ASSAY FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA
07/06/2000WO2000039313A1 PLASTID TRANSFORMATION OF $i(BRASSICA)
07/06/2000WO2000039312A1 Dna sequences containing a transfer mechanism by conjugation
07/06/2000WO2000039311A1 Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
07/06/2000WO2000039309A1 GRAM-POSITIVE BACTERIA DEPRIVED OF HtrA PROTEASIC ACTIVITY AND THEIR USES
07/06/2000WO2000039308A1 Ikk3 kinase
07/06/2000WO2000039307A2 Recombinant bacterial strains for the production of natural nucleosides and modified analogues thereof
07/06/2000WO2000039306A2 Detergent compositions comprising phenol oxidizing enzymes from fungi
07/06/2000WO2000039305A1 PYRUVATE CARBOXYLASE FROM $i(CORYNEBACTERIUM GLUTAMICUM)
07/06/2000WO2000039304A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/06/2000WO2000039303A2 Modified hiv env polypeptides
07/06/2000WO2000039302A2 Improved expression of hiv polypeptides and production of virus-like particles
07/06/2000WO2000039301A2 Methods for using mycobacterium tuberculosis molecules as immunological adjuvants
07/06/2000WO2000039300A1 Control of gene expression in eukaryotes
07/06/2000WO2000039299A2 Streptococcus antigens
07/06/2000WO2000039298A1 Chimeric gene encoding the antigenic determinants of four proteins of l. infantum
07/06/2000WO2000039297A2 Il-1 related polypeptides
07/06/2000WO2000039296A1 Lectin s3939 dna and polypeptides
07/06/2000WO2000039295A1 Member of the tnf ligand family
07/06/2000WO2000039294A1 Porcine cells incapable of expressing cd40 antigen, for xenotransplantation
07/06/2000WO2000039293A2 Agent for inhibiting the regeneration of tissue
07/06/2000WO2000039292A2 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells
07/06/2000WO2000039291A1 Virus-resistant transgenic plants expressing l3
07/06/2000WO2000039289A2 Endo-beta-1,4-xylanase inhibitor aus weizenmehl und seine wirkung auf verschiedene xylanasen
07/06/2000WO2000039287A2 A. fumigatus acetyl coenzyme-a carboxylase genes and polypeptides and uses thereof
07/06/2000WO2000039285A2 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
07/06/2000WO2000039283A1 Use of cd40 engagement to alter t cell receptor usage
07/06/2000WO2000039280A2 Leukocyte-derived interferon preparations
07/06/2000WO2000039279A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
07/06/2000WO2000039278A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
07/06/2000WO2000039275A2 Multiple shear stress responsive elements (ssre) and methods of use thereof
07/06/2000WO2000039165A1 Serine protease inhibitor
07/06/2000WO2000039164A1 Novel guanosine triphosphate (gtp)-binding protein-coupled receptor protein
07/06/2000WO2000039162A1 Human wnt-7a polypeptide and polynucleotide
07/06/2000WO2000039160A2 Caspase-8 interacting proteins
07/06/2000WO2000039159A1 Superantigens
07/06/2000WO2000039158A1 Chlamydia antigens and corresponding dna fragments and uses thereof
07/06/2000WO2000039157A1 Chlamydia antigens and corresponding dna fragments and uses thereof
07/06/2000WO2000039151A1 Neutralizing assay using human papillomavirus virus-like particles
07/06/2000WO2000039147A1 Dna molecules encoding splice variants of the human melanocortin 1 receptor protein
07/06/2000WO2000039146A1 Miniribozymes active at low magnesium ion concentrations
07/06/2000WO2000039145A1 Targeted gene transfer using g protein coupled receptors
07/06/2000WO2000039136A2 Human brainiac-5
07/06/2000WO2000038838A1 Apparatus and methods for efficient processing of biological samples on slides
07/06/2000WO2000038836A1 Tissue collection devices containing biosensors
07/06/2000WO2000038743A1 Removal of biological contaminants
07/06/2000WO2000038737A2 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
07/06/2000WO2000038713A1 Agonists or antagonists of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines
07/06/2000WO2000038709A1 Treatment of hyperproliferative disorders using casein kinase i
07/06/2000WO2000038707A1 Method for the treatment of bone loss
07/06/2000WO2000038706A2 Methods for treating cancer and for mediating chemotaxis of dendritic cells
07/06/2000WO2000038704A1 Use of peptide
07/06/2000WO2000038583A1 Methods and compositions for improving the developmental ability and quality of pre-implantation embryos
07/06/2000WO2000038518A1 Efficient and stable (in vivo) gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
07/06/2000WO2000038517A1 Methods for reducing adverse side effects associated with cellular transplantation
07/06/2000WO2000038515A1 Peptide mimics useful for treating disease
07/06/2000WO2000024899A3 Interleukin-1 homolog zil1a4
07/06/2000WO2000022125A3 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
07/06/2000WO2000022124A3 Methods and compositions to induce antitumor response
07/06/2000WO2000021988A3 Human ankyrin family protein
07/06/2000WO2000020619A3 Secreted renilla luciferase
07/06/2000WO2000020612A3 Therapeutically active proteins in plants
07/06/2000WO2000020607A3 Chimaeric proteins between members of tgf-beta superfamily
07/06/2000WO2000020591A3 Tgf-beta superfamily mutant members, including morphogenic proteins
07/06/2000WO2000020588A3 Bone marrow-derived serum proteins
07/06/2000WO2000020584A3 Human gene expressed in cancers of prostate, bladder, pancreas and colon, 36p1a6
07/06/2000WO2000020452A3 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response
07/06/2000WO2000020025A3 Akt compositions for enhancing survival of cells
07/06/2000WO2000020020A3 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease
07/06/2000WO2000018954A3 Use of pex in the treatment of metabolic bone diseases
07/06/2000WO2000018903A3 Inducible genetic suppression of cellular excitability
07/06/2000WO2000017355A3 Human cytoskeleton associated proteins
07/06/2000WO2000017222A8 31 human secreted proteins
07/06/2000WO2000016061B1 Method for diagnosing the active stage of a cytomegalovirus infection in human substrates
07/06/2000WO2000015827A3 Bacterial strains for the production of 2-keto-l-gulonic acid
07/06/2000WO2000015770A3 Human serine/threonine protein kinases
07/06/2000WO2000014222A3 Gabab receptor subtypes gabab-r1c and gabab-r2 and heterodimers thereof
07/06/2000WO2000014219A3 Peptide nucleic acid-oligoadenylate chimeric molecules
07/06/2000WO2000014206A3 Mutant egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
07/06/2000WO2000013703A3 Methods of treating hypertension and compositions for use therein
07/06/2000WO2000009727A8 Dna shuffling to produce herbicide selective crops
07/06/2000WO2000009698A3 Compounds useful to affect resistance in plants and methods related thereto
07/06/2000WO2000009689A3 A single gene encoding aortic-specific and striated-specific muscle cell isoforms, its regulatory sequences and uses thereof
07/06/2000WO2000005414A9 Linking gene sequence to gene function by three dimensional (3d) protein structure determination
07/06/2000WO2000003017A3 Enhancer elements for increased translation in plant plastids
07/06/2000WO2000000627A3 Fatty acid hydroperoxide lyase nucleic acid sequences
07/06/2000WO2000000616A3 Marburg virus vaccines
07/06/2000WO1999067367A9 DNA ENCODING OAT ACETYL CoA CARBOXYLASE
07/06/2000WO1999063115A9 Use of cathepsin s in the diagnosis and treatment of endometriosis
07/06/2000WO1999063087A9 G-protein coupled receptor, named 2871 receptor
07/06/2000WO1999061600A9 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
07/06/2000WO1999054461A3 Human nucleic acid sequences of endometrium tumour tissue
07/06/2000WO1999054448A3 Human nucleic acid sequences, increased expression thereof in uterus myoma tissue
07/06/2000WO1999054447A3 Human nucleic acid sequences of bladder tumour tissue
07/06/2000WO1999053040A3 Human nucleic acid sequences from ovarian tumour tissue
07/06/2000WO1999051727A3 Human nucleic acid sequences of normal ovary tissue
07/06/2000WO1999047655A3 Human nucleic acid fragments with heightened expression in normal breast tissue
07/06/2000WO1999047535A9 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS
07/06/2000WO1999046375A3 Human nucleic acid sequences from prostate tissue
07/06/2000WO1999046374A3 Human nucleic acid sequences from prostate tumour tissue
1 ... 3217 3218 3219 3220 3221 3222 3223 3224 3225 3226 3227 3228 3229 3230 3231 3232 3233 3234 3235 3236 3237 ... 4023